Reiss A, Gulkarov S, Pinkhasov A, Sheehan K, Srivastava A, Leon J
Medicina (Kaunas). 2024; 60(1).
PMID: 38256338
PMC: 10819522.
DOI: 10.3390/medicina60010077.
Chedrawe E, Sathe A, White J, Ory J, Ramasamy R
Androg Clin Res Ther. 2023; 3(1):180-186.
PMID: 36684061
PMC: 9850445.
DOI: 10.1089/andro.2021.0035.
Masuda H, Mikami K, Otsuka K, Hou K, Suyama T, Araki K
In Vivo. 2021; 35(6):3489-3493.
PMID: 34697186
PMC: 8627764.
DOI: 10.21873/invivo.12650.
Shigehara K, Izumi K, Nakashima K, Kawaguchi S, Nohara T, Kadono Y
Transl Androl Urol. 2021; 9(6):2533-2540.
PMID: 33457227
PMC: 7807326.
DOI: 10.21037/tau-20-901.
Casimiro I, Cohen R
J Endocr Soc. 2019; 3(4):734-736.
PMID: 30931422
PMC: 6436763.
DOI: 10.1210/js.2018-00367.
Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results from a single institution experience.
Challapalli A, Edwards S, Abel P, Mangar S
Clin Transl Radiat Oncol. 2018; 10:29-35.
PMID: 29928703
PMC: 6008629.
DOI: 10.1016/j.ctro.2018.03.002.
Ameliorating effect of decoction combined with Fructus ) on menopausal sweating and serum hormone profiles in a rat model.
Wang S, Wu F, Zhang Y, Zhang L, Su J, Wong H
Chin Med. 2016; 11:47.
PMID: 27895702
PMC: 5118901.
DOI: 10.1186/s13020-016-0117-6.
Risk factors, pathophysiology, and treatment of hot flashes in cancer.
Fisher W, Johnson A, Elkins G, Otte J, Burns D, Yu M
CA Cancer J Clin. 2013; 63(3):167-92.
PMID: 23355109
PMC: 3640615.
DOI: 10.3322/caac.21171.
Mechanism of hot flashes.
Vilar-Gonzalez S, Perez-Rozos A, Cabanillas-Farpon R
Clin Transl Oncol. 2011; 13(3):143-7.
PMID: 21421458
DOI: 10.1007/s12094-011-0633-x.
Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor?.
Kokolus K, Hong C, Repasky E
Int J Hyperthermia. 2010; 26(7):662-80.
PMID: 20849261
PMC: 3012377.
DOI: 10.3109/02656736.2010.507235.
Managing the low-socioeconomic-status prostate cancer patient.
Rayford W
J Natl Med Assoc. 2006; 98(4):521-30.
PMID: 16623064
PMC: 2569254.
Complications of androgen-deprivation therapy in men with prostate cancer.
Chen A, Petrylak D
Curr Urol Rep. 2005; 6(3):210-6.
PMID: 15869725
DOI: 10.1007/s11934-005-0009-2.
Complications of androgen deprivation therapy in men with prostate cancer.
Chen A, Petrylak D
Curr Oncol Rep. 2004; 6(3):209-15.
PMID: 15066232
DOI: 10.1007/s11912-004-0051-0.
